SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-122855
Filing Date
2015-04-08
Accepted
2015-04-08 16:30:36
Documents
4
Period of Report
2015-05-21
Effectiveness Date
2015-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d826537ddef14a.htm DEF 14A 644300
2 GRAPHIC g826537g25o33.jpg GRAPHIC 8319
3 GRAPHIC g826537g29l65.jpg GRAPHIC 8930
4 GRAPHIC g826537g64d68.jpg GRAPHIC 12703
  Complete submission text file 0001193125-15-122855.txt   687203
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 15759373
SIC: 2834 Pharmaceutical Preparations